A roundup of current health news includes Johnson & Johnson's $2 billion investment in a new manufacturing facility, CVS ...

Investors who own ABBV stock may stay invested as the company has faced its biggest challenge quite well and looks set to ...

The regulator said it withdrew authorisation for the drug on Sept. 25. It added that the authorisation holder, listed as ...

The insurers are looking to disrupt Big Pharma's model of distributing drugs. One of them's even offering to give them to ...

With Tremfya also securing approval in UC earlier this month, competition promises to be fierce among the IL-23s, according to .EXTON, PA, Oct. 01, 2024 (GLOBE NEWSWIRE) -- The past twelve months have ...

Office of Prescription Drug Promotion (OPDP) recently sent an Untitled Letter to AbbVie, Inc., regarding a television ad starring Serena Williams for its migraine medicine Ubrelvy. According to the ...

BeiGene aims to be a next-generation oncology innovator by broadening its drug and pipeline portfolio to various solid tumors in addition to blood cancers. As such, it been actively investing to build ...

AbbVie (ABBV) stock price has done well this year as it surged to a record high of $200. It has jumped by more than 32% this ...

17 long-term dividend growth companies will announce their annual increases in October. I provide predictions of the dividend ...

Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization (CDMO) and part of ...

Leerink Partners analyst David Risinger has maintained their neutral stance on ABBV stock, giving a Hold rating on September 13. David ...

AbbVie announced positive topline results from its Phase III TEMPO-1 trial for tavapadon as a monotherapy for early Parkinson ...